Clinical Trials Manager- Early Development Oncology
Gilead SciencesFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Millbrae, California, United States
Key technologies and capabilities for this role
Common questions about this position
The role requires a minimum of 3 days a week of onsite presence (or more as business needs require) in either of our California or New Jersey offices.
Candidates need to be a seasoned physician with a strong clinical background, passion for drug development, and expertise in clinical development, including designing and conducting clinical trials, medical monitoring, and collaboration across teams.
This information is not specified in the job description.
You will be a key member of cross-functional Development Teams and Clinical Study Teams, collaborating closely with biomarker, discovery, translational research scientists, toxicologists, clinical pharmacologists, drug safety specialists, regulatory representatives, Global Clinical Operations, and external partners.
Strong candidates are highly accomplished professionals with dedication to scientific rigor, meticulous attention to detail, deep passion for creating new medicines, and commitment to advancing medical research and improving patient outcomes.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.